Results 11 to 20 of about 273,405 (257)

Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review

open access: yesReviews in Cardiovascular Medicine
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk.
Sara Veneziano   +4 more
doaj   +2 more sources

Isolated tricuspid valve regurgitation [PDF]

open access: yes, 2023
This thesis investigated isolated tricuspid valve regurgitation. The tricuspid valve is the valve that separates the right atrium from the right ventricle. This valve has been disregarded for decades, but it has been demonstrated that tricuspid valve regurgitation was associated with reduced survival.
Sala, Alessandra
openaire   +7 more sources

Tricuspid Valve Is Transcriptionally Active During Prolonged Pressure Overload, Right‐Sided Heart Failure, and Valve Regurgitation

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Right‐sided heart failure (RHF), in the presence of tricuspid valve regurgitation, results from left‐sided heart failure, pulmonary hypertension (PH), or heart malformations.
Austin Goodyke   +10 more
doaj   +2 more sources

Tricuspid Valve Repair for a Patient with Congenital Isolated Severe Tricuspid Regurgitation

open access: yesArchives of Clinical and Experimental Surgery, 2013
Severe tricuspid regurgitation commonly results from left-sided heart disease and secondary pulmonary hypertension, while isolated tricuspid regurgitation requiring surgical intervention is extremely rare.
Manabu Shiraishi   +3 more
doaj   +2 more sources

Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints [PDF]

open access: yes, 2023
Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even ...
Topilsky, Yan   +58 more
core   +6 more sources

Update on Transcatheter Treatment of Mitral and Tricuspid Valve Regurgitation. [PDF]

open access: yes, 2023
PURPOSE OF REVIEW Mitral and tricuspid regurgitation represents a clinical challenge. They are associated with a poor prognosis, and many patients are not eligible for conventional surgery.
Boone, R.H.   +21 more
core   +1 more source

Update on Transcatheter Tricuspid Valve Replacement Therapies

open access: yesFrontiers in Cardiovascular Medicine, 2021
Severe tricuspid regurgitation is relatively common, especially in the elderly, and portends poor survival. Neither medical therapy nor conventional surgery is efficacious for most patients.
Ythan H. Goldberg   +3 more
doaj   +1 more source

Transcatheter Double Valve Replacement to Treat Aortic Stenosis and Severe Tricuspid Regurgitation with 3D Printing Guidance after Mechanical Mitral Valve Replacement

open access: yesJournal of Cardiovascular Development and Disease, 2022
Background: Transcatheter treatments of tricuspid regurgitation (TR) have been emerging as alternatives for high-risk patients. In contrast to the immobilization of the common transcatheter tricuspid device, using a radial force-independent stent valve ...
Mengen Zhai   +4 more
doaj   +1 more source

[Transcatheter Treatment of Severe Tricuspid Regurgitation]. [PDF]

open access: yes, 2020
Transcatheter Treatment of Severe Tricuspid Regurgitation Abstract. Severe tricuspid regurgitation can lead to increased morbidity and mortality due to clinical symptoms and impairment of organ function. With the emergence of new interventional treatment
Brugger, Nicolas   +5 more
core   +1 more source

Edge‐to‐edge tricuspid valve repair for severe tricuspid regurgitation 20 years after cardiac transplantation

open access: yesESC Heart Failure, 2020
Tricuspid valve regurgitation in orthotopic heart transplant recipients is common. Surgical corrections have been the mainstay of the treatment for diuretic‐refractory heart failure due to severe tricuspid regurgitation. However, post‐transplant patients
Naoki Misumida   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy